Form 4: Cigna Group Executive Noelle K. Eder Reports Acquisition of Shares and Stock Options
SEC Form 4 Filing
Noelle K. Eder, EVP and Global Chief Information Officer of Cigna Group, reports the acquisition of common stock and stock options.
Summary
- On February 28, 2024, Noelle K. Eder, an Executive Vice President and Global Chief Information Officer at Cigna Group, reported transactions involving Cigna Group's common stock.
- Eder acquired 2,657 shares of common stock at $0.00, which are restricted shares vesting in three equal annual installments starting March 1, 2025.
- Additionally, Eder acquired 9,677 employee stock options with an exercise price of $336.475, vesting in three equal annual installments beginning March 1, 2025, and expiring on February 28, 2034.
- Eder also acquired common stock through participation in The Cigna Group's 401(k) Plan.
- Following these transactions, Eder directly owns 18,581 shares of Cigna Group common stock and indirectly owns shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It reflects routine transactions and does not inherently indicate positive or negative performance for the company.
Positives
- The acquisition of shares and stock options by a high-ranking executive could be interpreted as a sign of confidence in the company's future performance.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules for the restricted shares and stock options extend into the future.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies. This filing indicates changes in beneficial ownership by a Cigna Group executive.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives, ensuring transparency and compliance with SEC regulations.
- The vesting schedules for the restricted shares and stock options are typical compensation mechanisms used by companies to incentivize and retain key personnel.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
- The vesting schedules for the restricted shares and stock options may incentivize the executive to contribute to the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 2024-01-02 | Date of Power of Attorney execution. |
| 2024-02-28 | Date of the reported transactions (acquisition of shares and stock options). |
| 2024-03-01 | Date of Form 4 signature. |
| 2025-03-01 | First vesting date for the restricted shares and stock options. |
| 2034-02-28 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.